JP7693709B2 - １，５－ジヒドロ－２，４－ベンゾジアゼピン－３－オン誘導体及びその使用 - Google Patents
１，５－ジヒドロ－２，４－ベンゾジアゼピン－３－オン誘導体及びその使用 Download PDFInfo
- Publication number
- JP7693709B2 JP7693709B2 JP2022563189A JP2022563189A JP7693709B2 JP 7693709 B2 JP7693709 B2 JP 7693709B2 JP 2022563189 A JP2022563189 A JP 2022563189A JP 2022563189 A JP2022563189 A JP 2022563189A JP 7693709 B2 JP7693709 B2 JP 7693709B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- formula
- compound
- methyl
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010330893 | 2020-04-26 | ||
| CN202010330893.1 | 2020-04-26 | ||
| CN202110288141 | 2021-03-17 | ||
| CN202110288141.8 | 2021-03-17 | ||
| PCT/CN2021/089660 WO2021218863A1 (zh) | 2020-04-26 | 2021-04-25 | 1,5-二氢-2,4-苯二氮䓬-3-酮衍生物及其应用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023522078A JP2023522078A (ja) | 2023-05-26 |
| JP2023522078A5 JP2023522078A5 (https=) | 2024-04-11 |
| JP7693709B2 true JP7693709B2 (ja) | 2025-06-17 |
Family
ID=78374068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022563189A Active JP7693709B2 (ja) | 2020-04-26 | 2021-04-25 | １，５－ジヒドロ－２，４－ベンゾジアゼピン－３－オン誘導体及びその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12559471B2 (https=) |
| EP (1) | EP4144725B1 (https=) |
| JP (1) | JP7693709B2 (https=) |
| KR (1) | KR102832951B1 (https=) |
| CN (1) | CN115667236B (https=) |
| AU (1) | AU2021262281B2 (https=) |
| BR (1) | BR112022021228A2 (https=) |
| CA (1) | CA3172692C (https=) |
| WO (1) | WO2021218863A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115605202B (zh) | 2020-03-26 | 2025-10-28 | 盐野义制药株式会社 | 具有血清素受体结合活性的芳香族杂环衍生物 |
| CN121039114A (zh) | 2023-04-21 | 2025-11-28 | 江苏恩华药业股份有限公司 | 1,5-二氢-2,4-苯二氮䓬-3-酮衍生物枸橼酸盐的晶型、制备方法及其应用 |
| WO2025044768A1 (zh) * | 2023-08-29 | 2025-03-06 | 江苏恩华药业股份有限公司 | 1,5-二氢-2,4-苯二氮䓬-3-酮衍生物的制备方法和其中间体及其制备方法 |
| CN120329280A (zh) * | 2024-01-17 | 2025-07-18 | 江苏恩华药业股份有限公司 | 取代的1,2,4-四氢-3h-苯并二氮䓬-3-酮衍生物及其应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008132139A2 (en) | 2007-04-27 | 2008-11-06 | Ucb Pharma S.A. | New heterocyclic derivatives useful for the treatment of cns disorders |
| JP2009508807A (ja) | 2005-07-15 | 2009-03-05 | エーエムアール テクノロジー インコーポレイテッド | アリール置換およびヘテロアリール置換テトラヒドロベンズアゼピンならびにノルエピネフリン、ドーパミンおよびセロトニンの再取り込みを遮断するためのその使用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60161986A (ja) * | 1983-12-24 | 1985-08-23 | Nippon Soda Co Ltd | イミダゾ（１，５−ａ）ピリジン−３−オン誘導体及びその製造方法 |
| ES2197160T3 (es) * | 1992-12-21 | 2004-01-01 | Smithkline Beecham Corp | Antagonistas fibronogeno bicicliclos. |
| EP0960104B1 (en) * | 1996-04-17 | 2004-06-16 | Bristol-Myers Squibb Pharma Company | N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors |
| UA60311C2 (uk) * | 1996-10-02 | 2003-10-15 | Смітклайн Бічам Корпорейшн | Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція |
| GT199800109A (es) * | 1997-08-06 | 2000-01-13 | Derivados de n-sulfonilglicinalquiniloxifenetilamida microbicidas. | |
| JP2003503476A (ja) * | 1999-07-06 | 2003-01-28 | バーテックス ファーマシューティカルズ インコーポレイテッド | 環化アミド誘導体 |
| SI1720836T1 (sl) * | 2004-02-25 | 2014-06-30 | Eli Lilly And Company | 6-substituirani 2,3,4,5-tetrahidro-1h-benzo (d)azepini kot agonisti 5-ht2c receptorja |
| US7473778B2 (en) * | 2005-12-24 | 2009-01-06 | Boehringer Ingelheim International Gmbh | 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)-one |
| JP5502733B2 (ja) * | 2007-07-26 | 2014-05-28 | エフ．ホフマン−ラ ロシュ アーゲー | ５−ｈｔ２ａ及びｄ３受容体の二重のモジュレーター |
| US9309200B2 (en) * | 2011-05-12 | 2016-04-12 | AbbVie Deutschland GmbH & Co. KG | Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| EP3409658B9 (en) * | 2016-01-29 | 2024-07-17 | ONO Pharmaceutical Co., Ltd. | Tetrahydronaphthalene derivative |
-
2021
- 2021-04-25 JP JP2022563189A patent/JP7693709B2/ja active Active
- 2021-04-25 CA CA3172692A patent/CA3172692C/en active Active
- 2021-04-25 BR BR112022021228A patent/BR112022021228A2/pt unknown
- 2021-04-25 KR KR1020227040086A patent/KR102832951B1/ko active Active
- 2021-04-25 EP EP21796540.9A patent/EP4144725B1/en active Active
- 2021-04-25 WO PCT/CN2021/089660 patent/WO2021218863A1/zh not_active Ceased
- 2021-04-25 CN CN202180029971.7A patent/CN115667236B/zh active Active
- 2021-04-25 AU AU2021262281A patent/AU2021262281B2/en active Active
-
2022
- 2022-10-20 US US18/048,340 patent/US12559471B2/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009508807A (ja) | 2005-07-15 | 2009-03-05 | エーエムアール テクノロジー インコーポレイテッド | アリール置換およびヘテロアリール置換テトラヒドロベンズアゼピンならびにノルエピネフリン、ドーパミンおよびセロトニンの再取り込みを遮断するためのその使用 |
| WO2008132139A2 (en) | 2007-04-27 | 2008-11-06 | Ucb Pharma S.A. | New heterocyclic derivatives useful for the treatment of cns disorders |
Also Published As
| Publication number | Publication date |
|---|---|
| BR112022021228A2 (pt) | 2022-12-06 |
| JP2023522078A (ja) | 2023-05-26 |
| EP4144725B1 (en) | 2025-11-26 |
| KR102832951B1 (ko) | 2025-07-10 |
| AU2021262281A1 (en) | 2022-11-24 |
| US12559471B2 (en) | 2026-02-24 |
| EP4144725A1 (en) | 2023-03-08 |
| WO2021218863A1 (zh) | 2021-11-04 |
| CN115667236A (zh) | 2023-01-31 |
| CA3172692C (en) | 2024-05-14 |
| AU2021262281B2 (en) | 2024-11-28 |
| US20230132621A1 (en) | 2023-05-04 |
| CA3172692A1 (en) | 2021-11-04 |
| CN115667236B (zh) | 2024-04-26 |
| EP4144725C0 (en) | 2025-11-26 |
| KR20230004662A (ko) | 2023-01-06 |
| EP4144725A4 (en) | 2023-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7693709B2 (ja) | １，５－ジヒドロ－２，４－ベンゾジアゼピン－３－オン誘導体及びその使用 | |
| JP5416696B2 (ja) | オキサジアゾール誘導体およびそれらの代謝型グルタミン酸受容体増強剤としての使用 | |
| JP6859325B2 (ja) | ヒトキチナーゼ阻害剤として有用な置換アミノトリアゾール | |
| US7799792B2 (en) | Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators 841 | |
| CN101511802A (zh) | 螺唑烷酮化合物及其作为代谢型谷氨酸受体增效剂的用途 | |
| CA2570197C (en) | Nk1 antagonists | |
| JP2023522078A5 (https=) | ||
| KR20140096322A (ko) | 아미노 알킬 치환 n-티에닐벤즈아미드 유도체 | |
| JP2009519929A (ja) | オキサゾリジノン化合物及び代謝型グルタミン酸レセプター増強剤としてのそれらの使用 | |
| CN116444484B (zh) | 1,5-二氢-2,4-苯二氮䓬-3-酮衍生物的盐及应用 | |
| JP2008531679A (ja) | オキシトシンアンタゴニストとしての１，２，４−トリアゾール誘導体とその使用 | |
| JP2013249258A (ja) | グリシントランスポーター阻害物質 | |
| KR20180014732A (ko) | 이미다조디아제핀 화합물 | |
| HK40080583A (en) | 1,5-dihydro-2,4-benzodiazepine-3-one derivative and application thereof | |
| HK40080583B (zh) | 1，5-二氢-2，4-苯二氮䓬-3-酮衍生物及其应用 | |
| KR20140009308A (ko) | 글리신 트랜스포터 저해 물질 | |
| WO2012115066A1 (ja) | グリシントランスポーター阻害物質 | |
| HK1166978B (en) | Oxadiazole derivatives and their use as metabotropic glutamate receptor -842 potentiators |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240328 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240328 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250218 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20250220 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250515 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20250527 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20250605 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7693709 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |